Ohio Medicaid does cover Ozempic, but only for people with Type 2 diabetes and only after prior authorization. The drug sits on the non-preferred tier of the state’s Unified Preferred Drug List, so your prescriber generally has to show that a preferred GLP-1 won’t work before the program will pay. Ohio Medicaid will not cover Ozempic for weight loss under any circumstances, because state rules bar coverage of obesity drugs.1Ohio Legislative Service Commission. Ohio Administrative Code §5160-9-03
What You Need To Get Ozempic Approved
Coverage requires a documented diagnosis of Type 2 diabetes. Ohio Medicaid has required that claims for preferred GLP-1 receptor agonists include a Type 2 diabetes diagnosis since at least November 2025, and the program does not authorize non-FDA-approved uses such as prediabetes or weight loss.2Ohio Medicaid SPBM. Single Pharmacy Benefit Manager
Because Ozempic is non-preferred, your prescriber typically has to document that you tried and failed one of the preferred GLP-1s, or that you have a medical reason you can’t take one, such as an allergy, drug interaction, or contraindication.3Ohio Department of Medicaid. Unified Preferred Drug List Effective January 1, 2026 The preferred options are Byetta (exenatide), Trulicity (dulaglutide), and Victoza (liraglutide). Ozempic, Mounjaro (tirzepatide), and Rybelsus (oral semaglutide) all require prior authorization as non-preferred products.2Ohio Medicaid SPBM. Single Pharmacy Benefit Manager
Prior authorization requests go through Gainwell Technologies, Ohio Medicaid’s Single Pharmacy Benefit Manager for both managed care and fee-for-service members. Your prescriber can submit requests electronically, by fax at 833-679-5491, or by phone at 833-491-0344. Decisions are issued within 24 hours.2Ohio Medicaid SPBM. Single Pharmacy Benefit Manager
Why Weight Loss Is Not a Covered Use
Ohio Administrative Code §5160-9-03, last updated in February 2024, states that “drugs for the treatment of obesity” are non-covered by the Ohio Medicaid pharmacy program. The rule goes further and makes obesity drugs ineligible for prior authorization, so there is no case-by-case exception available.1Ohio Legislative Service Commission. Ohio Administrative Code §5160-9-03
This exclusion rests on a federal option. Section 1927 of the Social Security Act generally requires Medicaid to cover FDA-approved drugs for medically accepted uses, but it carves out agents used for “anorexia, weight loss, or weight gain.” States must cover GLP-1s for indications like Type 2 diabetes; covering them for obesity is optional, and Ohio has opted out.4KFF. Medicaid Coverage of and Spending on GLP-1s
What About Wegovy, Mounjaro, and Zepbound?
Mounjaro is covered for Type 2 diabetes with prior authorization on the same non-preferred terms as Ozempic.2Ohio Medicaid SPBM. Single Pharmacy Benefit Manager Zepbound (tirzepatide for weight loss) is not covered by Ohio Medicaid for any indication.5Plexus DX. GLP-1 in Ohio
Wegovy (semaglutide for weight management) is different. In January 2026, Ohio Medicaid’s Pharmacy and Therapeutics Committee made Wegovy preferred with clinical prior authorization, but only for two narrow, non-obesity indications: cardiovascular risk reduction and metabolic dysfunction-associated steatohepatitis (MASH). Standard weight-loss use is still excluded.6Ohio Department of Medicaid. P&T Committee Meeting Minutes, January 7, 2026
For the cardiovascular (MACE) indication, you must be at least 18, have a BMI of 27 or higher, have no Type 1 or Type 2 diabetes (A1C below 6.5%), and have a documented history of prior heart attack, prior stroke, or symptomatic peripheral artery disease. You must also already be on an antiplatelet agent, a lipid-lowering drug, and an antihypertensive.6Ohio Department of Medicaid. P&T Committee Meeting Minutes, January 7, 2026
For the MASH indication, you must be at least 18 with documented noncirrhotic MASH and moderate to advanced fibrosis (stage F2 or F3), confirmed by liver biopsy within the past 24 months or by other diagnostic tests. You must be following a reduced-calorie diet and increased physical activity, and must not be on another MASH treatment or another GLP-1.6Ohio Department of Medicaid. P&T Committee Meeting Minutes, January 7, 2026
Authorizations last 180 days. Renewal requires at least 5% weight loss, medication adherence of at least 80% of days covered, and, for the cardiovascular indication, a continued A1C below 6.5%.6Ohio Department of Medicaid. P&T Committee Meeting Minutes, January 7, 2026
If Your Ozempic Prescription Is Denied
You have the right to appeal, and the route depends on who denied it.
If a managed care plan issued the denial, appeal to the plan within 60 days of the mailing date on the denial notice. The plan has 15 days to resolve the appeal, or 72 hours if you request an expedited appeal because of a health risk. If the plan upholds the denial, you can request a state hearing from the Ohio Department of Job and Family Services Bureau of State Hearings within 120 days of the plan’s decision.7Disability Rights Ohio. Medicaid Appeals Overview
If the denial came from outside managed care, you have 90 days from the mailing date on the notice to request a state hearing.8Ohio Mental Health. Appeals Requests go to the ODJFS Bureau of State Hearings at P.O. Box 182825, Columbus, Ohio 43218-2825, by fax at 614-728-9574, by email to bsh@jfs.ohio.gov, or online. Hearing decisions are typically mailed within 70 days.7Disability Rights Ohio. Medicaid Appeals Overview
To keep receiving benefits while you appeal, file within 15 days of the mailing date on the denial notice and before your current authorization expires. If the appeal is unsuccessful, you may have to repay benefits received during the process.8Ohio Mental Health. Appeals For help navigating any of this, Disability Rights Ohio can be reached at 800-282-9181.7Disability Rights Ohio. Medicaid Appeals Overview